Hinweis-Modus ist eingeschaltet Ausschalten

HELX - Franklin Genomic Advancements ETF (USD) (US35473P5200)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.
 
(%)
US35473P5200
HELX ISIN
Exchange Traded Funds (ETF)
Fondstyp
Franklin Templeton Investments
Anbieter
38,44 USD
NAV pro Aktie | 20/07/2026
25/02/2020
Startdatum
1 Wiederholungen pro Jahr
Ausschüttung von Dividenden
CEOJLS
CFI
HELX
Ticker
Formed
Status
Equity
Investitionsobjekt
Biotech
Sektor
USA
Geographie
Russell 3000 Index
Benchmark
0.5 %
Gesamtkostenquote
28,83 Mio. USD
Gesamtes Fondsvermögen | 20/07/2026
28,83 Mio. USD
Aktien-Anlageklasse Volumen | 20/07/2026
Nein
UCITS

Rendite auf 20/07/2026, Cboe BZX Exchange

  • YTD
    -10,83 %
  • 1M
    -6,62 %
  • 3M
    -7,6 %
  • 6M
    -7,55 %
  • 1J
    24,21 %
  • 3J
    9 %
  • 5J
    -21,11 %
  • 10J
    -
Zum Börsenpreis einschliesslich Einkommenszahlungen

Letzte Daten zum
Zum Vergleichen hinzufügen

Kurse (HELX)

Entdecken Sie die umfangreichste Datenbank

1 000 000

Anleihen weltweit

100 000

Aktien

175 910

ETF & Funds

100 000

Indizes

Verwalten Sie Ihr Portfolio auf effizienteste Weise

  • Bond-Screener
  • Watchlist
  • Excel-Add-In

Kurs-Dynamik

HELX profile

The Franklin Genomic Advancements ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The Franklin Templeton Investments fund’s base currency is USD and the share class was registered 25.02.2020 with unique ISIN - US35473P5200. Main exchange is Cboe BZX Exchange and ticker symbol is HELX. The total expense ratio is 0.5%. The Franklin Genomic Advancements ETF (USD) pays dividends 1 time(s) per year.

Struktur HELX auf 20/07/2026

Wertpapier Wertpapier
GUARDANT HEALTH INC GH 9,31%
NATERA INC NTRA 7,49%
KRYSTAL BIOTECH INC KRYS 6%
LIGAND PHARMACEUTICALS LGND 4,46%
ADAPTIVE BIOTECHNOLOGIES ADPT 4,22%
BRIDGEBIO PHARMA INC BBIO 3,94%
UNITED THERAPEUTICS CORP UTHR 3,56%
ELI LILLY & CO LLY 2,93%
VERTEX PHARMACEUTICALS IN VRTX 2,76%
TRAVERE THERAPEUTICS INC TVTX 2,63%
INSMED INC INSM 2,54%
TWIST BIOSCIENCE CORP TWST 2,51%
ASTRAZENECA PLC AZN 2,43%
CORTEVA INC CTVA 2,4%
SAMSUNG BIOLOGICS CO LTD 207940 2,37%
MEDPACE HOLDINGS INC MEDP 2,22%
CASH — 2,14%
REGENERON PHARMACEUTICALS REGN 2,01%
NEUROCRINE BIOSCIENCES IN NBIX 1,97%
ALNYLAM PHARMACEUTICALS I ALNY 1,84%
TEMPUS AI INC-CL A TEM 1,69%
VERACYTE INC VCYT 1,66%
ARGENX SE ARGX 1,58%
PTC THERAPEUTICS INC PTCT 1,45%
BIONTECH SE-ADR BNTX 1,42%
IONIS PHARMACEUTICALS INC IONS 1,33%
CHARLES RIVER LABORATORIE CRL 1,27%
STOKE THERAPEUTICS INC STOK 1,17%
GRAIL INC GRAL 1,14%
CAREDX INC CDNA 1,14%
REPLIGEN CORP RGEN 1,09%
SARTORIUS AG-VORZUG SRT3 0,91%
CADENCE DESIGN SYS INC CDNS 0,89%
CRISPR THERAPEUTICS AG CRSP 0,88%
THERMO FISHER SCIENTIFIC TMO 0,82%
IQVIA HOLDINGS INC IQV 0,82%
JAZZ PHARMACEUTICALS PLC JAZZ 0,82%
PRAXIS PRECISION MEDICINE PRAX 0,81%
ANAPTYSBIO INC ANAB 0,8%
AXSOME THERAPEUTICS INC AXSM 0,77%
HINGE HEALTH INC-A HNGE 0,77%
BEAM THERAPEUTICS INC BEAM 0,74%
DANAHER CORP DHR 0,63%
AGILENT TECHNOLOGIES INC A 0,59%
ULTRAGENYX PHARMACEUTICAL RARE 0,54%
QIAGEN N.V. — 0,51%
ARCUTIS BIOTHERAPEUTICS I ARQT 0,45%
RHYTHM PHARMACEUTICALS IN RYTM 0,41%
FIRST TRACKS BIOTHERAPEUT TRAX 0,38%
SAMSUNG EPISHOLDINGS CO L 0126Z0 0,35%
KINIKSA PHARMACEUTICALS I KNSA 0,34%
BIO-RAD LABORATORIES-A BIO 0,27%
BRISTOL-MYERS SQUIBB CO BMY 0,27%
NEUROGENE INC NGNE 0,27%
BEONE MEDICINES LTD-ADR ONC 0,26%
LIQUIDIA CORP LQDA 0,25%
TG THERAPEUTICS INC TGTX 0,25%
TARSUS PHARMACEUTICALS IN TARS 0,24%
GENEDX HOLDINGS CORP WGS 0,13%
WAVE LIFE SCIENCES LTD WVE 0,1%
RECURSION PHARMACEUTICALS RXRX 0,06%
OMNIAB INC - 12.5 EARNOUT 2200963 0%
OMNIAB INC - 15.00 EARNOU 2200964 0%
Net Current Assets — -0,02%
Andere - %

Andere ETFs und Fonds dieses Anbieters

Ähnliche Etf & Fonds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} Mio.
    NAV
    {{ item.expense_ratio }}
    Gesamtkostenquote
Sie müssen sich registrieren , um Zugriff zu erhalten.